Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Ivy Rx

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Ivy Rx head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 106 · Grade C

Ivy Rx

Visit Ivy Rx Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 74 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Ivy Rx a bad call — it's best for readers willing to confirm the medication, complete payment and renewal terms before choosing a glp-1 subscription. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
74
Transparency
90
88
Access Breadth
93
90
Clinical Oversight
92
82
Track Record
88
73
CoreAge RxBrief Score 94 · 74Ivy Rx

Price, coverage & the tracker

CoreAge RxIvy Rx
Brief Score94/100 (A)74/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm current price

Shared GLP-1 offer starts at $77; medication-specific total, prepaid term and renewal need confirmation.

Full price details

Compounded semaglutide offered; current medication quote unknown; earlier listing: From $175/mo (starting dose, compounded)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm current price

Shared GLP-1 offer starts at $77; medication-specific total, prepaid term and renewal need confirmation.

Full price details

Compounded tirzepatide offered; current medication quote unknown; earlier listing: From $275/mo (starting dose, compounded)

CoverageUS only; restrictions by state, confirmed at intakeConfirm medication-specific access for your location; reviewed public pages do not establish a current state roster
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Ivy Rx: The current $77 floor covers a shared GLP-1 listing, without a separate complete semaglutide or tirzepatide quote. Earlier molecule prices remain historical.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.